- PROSPECTIVE STUDENTS
- CURRENT STUDENTS
Since its inception in 2001, more than 100 students have earned their doctoral degrees through the NIH Oxford-Cambridge Scholars (OxCam) Program and have moved on to make exciting scientific discoveries in their research.
The numerous successes and achievements of our alumni has made it challenging to maintain a current database. We are striving to cultivate the relationships with our former students and take great pride in observing the development of these scholars’ careers. We look forward to providing constant updates on the remarkable accomplishments of our alumni and hope that their continued engagement will provide networking opportunities for our current students.
Ambika Bumb, PhD (Class of ’05)
Ambika Bumb, CEO and founder of Bikanta, was an NIH-Oxford and Marshall Scholar until 2009 when she earned her DPhil and moved on to complete two post-doctoral fellowships at the NIH, one in the National Cancer Institute and one in the National Heart, Lung, and Blood Institute. During her time in the program, and subsequent post-docs, she developed the nanodiamond technology that led to the development of her company in 2013. She has received recognition for her scientific achievements, including a profile piece in Nature (2011), labeling her a “successful young scientist on the fast-track”. Recently, Bikanta was selected to be a part of the Bay Bio Fellows All-Star Team (FAST) Advisory Program.
Paul Tesar, PhD (Class of ’03)
Paul Tesar completed the OxCam Program in 2007 after earning his DPhil from the University of Oxford. Following his postdoctoral fellowship at the NIH in the National Institute of Neurological Disorders and Stroke he returned to his undergraduate alma mater, Case Western Reserve University, as a faculty member in the Department of Genetics. He is now a member of the Center for Stem Cell and Regenerative Medicine and serves as the director of the Pluripotent Stem Cell Facility. In 2011, Paul was named a Robertson Investigator of the New York Stem Cell Foundation. More recently, Paul was highlighted in Neurology Today as an expert in his field on the subject of “Producing New Myelinated Cells”.